Interestingly, these follow-up findings showed that tau extracted from different human conditions, i.e. AD, progressive supranuclear palsy, and cortical basal degeneration, seeded with different potencies and resulted in different cell-type specificity of tau aggregate transmission [109]. The gene discussed is MAPT; the disease is Alzheimer disease.